Bright Lifecare's prescription services spinout has secured $15m in series B funding, following a $6m Intel-backed round last year.
India-based drug prescription management platform 1mg has raised Rs 1bn ($15m) in series B funding, a year after it spun out of health and wellness e-commerce company Bright Lifecare, Business Standard reported on Wednesday.
The funding came from Sequoia India, the local branch of US-based venture capital firm Sequoia Capital, as well as hedge fund sponsor Maverick Capital Ventures and investment firm Omidiyar Network.
Spun out of Bright Lifecare in April 2015, 1mg operates a platform that provides prescription…
